Osteoporosis Clinical Trials

Showing 621-640 of 690 trials

A School-Based Osteoporosis Prevention Program for Adolescent Girls

NCT00067925

The Incorporating More Physical Activity and Calcium in Teens (IMPACT) study was a behaviorally-based middle school nutrition and physical activity program for the prevention of osteoporosis. The goal of IMPACT was to increase calcium intake and physical activity to help build bone mass in girls.

Osteoporosis

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)718 participantsStarted Sep 2000

COMPLETEDPhase 3

Phase 3 Clinical Trial of Teriparatide in Japan

NCT00433160

To evaluate the efficacy of teriparatide based on measurements of bone mineral density at lumbar spine

Osteoporosis

Eli Lilly and Company207 participantsStarted Jan 2007

Aichi, Japan • Fukuoka, Japan • Hokkaido, Japan +13 more locations

A School-Based Osteoporosis Prevention Program for Adolescent Girls

Phase 3 Clinical Trial of Teriparatide in Japan

Related Searches

Raloxifene for Prevention of Bone Loss in Postmenopausal Patients Receiving Chronic Corticosteroid Therapy

Motor Control Exercise in Osteoporotic Women

Effects of Arzoxifene on Bone Fractures and Incidence of Breast Cancer

Bone Density of Large Newborn Infants and Infants of Diabetic Mothers

Efficacy of Nebido on Bone Mineral Density (BMD) in Hypogonadal Paraplegic Patients With Confirmed Osteoporosis

Randomized, Open, Parallel, Active Controlled Study on Fracture Prevention in Antiosteoporosis Treatment (OF Study)

Study Comparing Arzoxifene With Raloxifene in Women After Menopause With Osteoporosis

Markers of Bone Turnover in Saliva and How This Compares to Urine and Blood

Coventry Outcomes Study of Seniors (COSS): A Comparative Effectiveness Study to Evaluate the Effect of a Multidisciplinary Team's Intervention on the Incidence of Nonelective Hospitalizations in a Medicare Population

Effectiveness of Automated Inpatient Endocrinology Consultation for Osteoporotic Hip Fracture

In Vivo Hip Fracture Discrimination With Quantitative Computed Tomography (QCT)

Risedronate 75mg Dosed on 2 Consecutive Days Monthly in the Treatment of Osteoporosis in Postmenopausal Women

Case Control Study: Determinants of Osteoporosis in GOLD II COPD Patients.

ROSPA - Record on Satisfaction of Patients With Actonel 35 mg Once a Week

Study Evaluating TSE-424/Placebo/Raloxifene in Preventing Osteoporosis in Postmenopausal Women

Study of the Osteoprotector Effects of a Milk Product Based on Anthocyans and Enriched in Calcium and Vitamin D

Radiostereometric Analysis of Acetabular Wear and Periprosthetic Bone Mineral Density Changes in Hemiarthroplasties

Hormone Replacement Therapy in Relieving Menopausal Symptoms in Postmenopausal Women With Previous Stage I or Stage II Breast Cancer